Delivery Order SPE2DB25D3108-SPE2DB25FPDFY
Award Date 7/7/25
Potential Completion Date 7/28/25
Potential Value $3.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,188.32 delivery order contract is for the supply of XOLAIR 300 MG/2 ML AUTOINJECT 2ML, a pharmaceutical product. The contract is a firm fixed price award with an ultimate completion date of August 7, 2025. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XOLAIR 300 MG/2 ML AUTOINJECT 2ML, a pharmaceutical product, with a ceiling value of $3,188.32. The contract is a Firm Fixed Price Delivery Order, with a period of performance running through July 31, 2025. The award is not designated as a set-aside contract, indicating open...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of XOLAIR 300 MG/2 ML AUTOINJECT 2ML. The contract has a firm fixed price, non-set-aside designation, and a ceiling value of $25,506.56. The ultimate completion date is July 24, 2025. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award is for the delivery of XOLAIR 150 MG/ML SYRINGE-ML pharmaceutical products to the Defense Logistics Agency (DLA). The $1,440.70 firm fixed price delivery order was competitively awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of August 7, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
- This is a federal contract award by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XOLAIR 300 MG/2 ML AUTOINJECT 2ML, a pharmaceutical product, with a firm fixed price ceiling value of $4,782.48 and a completion date of July 2, 2025. The contract is a delivery order and does not have a set-aside designation, indicating open competition....
- This federal contract award is for the delivery of XOLAIR 150 MG/ML SYRINGEML, a pharmaceutical product, to the U.S. government. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract has a ceiling value of $34,576.32 and is a firm fixed-price delivery order. It has an ultimate completion date of June 17, 2025. The contract is not set aside and is open to full and open...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of XOLAIR 300 MG/2 ML AUTOINJECT 2ML medical supplies. The contract, with a ceiling value of $3,188.32, was awarded on July 10, 2025 and has an ultimate completion date of July 31, 2025. The contract is a Delivery Order type with a Firm Fixed Price pricing structure, awarded by the Defense Logistics Agency (DLA), a defense agency....
- This is a $3,188.32 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of XOLAIR 300 MG/2 ML AUTOINJECT 2ML, a pharmaceutical product, with a performance period through July 28, 2025. AmerisourceBergen also holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support...
- This federal contract award is for the delivery of XOLAIR 300 MG/2 ML AUTOINJECT 2ML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The $4,782.48 firm fixed-price delivery order has a period of performance through July 18, 2025 and was awarded on June 26, 2025 to prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. There is no set-aside designation indicated for this contract. The contract is part of...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a defense agency. The contract is a Delivery Order with a firm fixed price of $3,188.32 and an ultimate completion date of August 1, 2025. The contract is for the provision of XOLAIR 300 MG/2 ML AUTOINJECT 2ML, a pharmaceutical product, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...